Nifty

:

17196.70

Sensex

:

57696.46

-204.95 (-1.18%)
-764.83 (-1.31%)

Login

Nifty
Sensex

:
:

17196.70
57696.46

-204.95 (-1.18%)
-764.83 (-1.31%)

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

41/99

BSE: 524558 | NSE: NEULANDLAB

Watchlist

NSE BSE

1787.60

03-Dec-2021

Open
High
Low
Previous Close

1820.20
1838.90
1763.45
1812.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

29544
531.65
2844.40
977.40

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,293.54
31.75
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,444.31
0.28%
2.88

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.64
10.11
12.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.11
6.66
20.26

PAT CAGR (%)

10 Years
5 Years
3 Years

41.20
11.47
69.90

P:E (Median)

8 Years
5 Years
3 Years

32.71
37.63
38.36

P:BV (Average)

8 Years
5 Years
3 Years

2.96
2.87
2.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.50
14.55
14.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var%
Net Sales 257.85 241.39 6.82% 200.89 205.42 -2.21% 244.71 191.87 27.54% 245.39 203.62 20.51%
Expenses 215.06 200.63 7.19% 175.28 171.69 2.09% 219.27 161.87 35.46% 198.88 175.56 13.28%
EBITDA 42.79 40.76 4.98% 25.60 33.74 -24.13% 25.44 29.99 -15.17% 46.51 28.06 65.75%
EBIDTM 16.59% 16.89% 12.74% 16.42% 10.40% 15.63% 18.95% 13.78%
Other Income 0.29 0.61 -52.46% 2.06 0.70 194.29% 14.60 1.78 720.22% 0.20 1.02 -80.39%
Interest 3.56 3.51 1.42% 3.84 5.37 -28.49% 4.58 7.07 -35.22% 4.44 5.69 -21.97%
Depreciation 11.98 9.27 29.23% 11.83 8.86 33.52% 11.14 7.63 46.00% 10.41 7.82 33.12%
PBT 27.53 28.59 -3.71% 11.99 20.20 -40.64% 24.32 17.08 42.39% 31.86 15.57 104.62%
Tax 7.21 7.25 -0.55% 3.34 5.15 -35.15% 7.09 26.43 -73.17% 5.19 4.53 14.57%
PAT 20.33 21.34 -4.73% 8.65 15.06 -42.56% 17.23 -9.35 - 26.67 11.04 141.58%
PATM 7.88% 8.84% 4.30% 7.33% 7.04% -4.87% 10.87% 5.42%
EPS 15.88 16.67 -4.74% 6.76 11.76 -42.52% 13.46 -7.31 - 20.84 8.63 141.48%

Description Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var%
Net Sales 257.85 241.39 6.82% 200.89 205.42 -2.21% 244.71 191.64 27.69% 245.39 203.84 20.38%
Expenses 215.01 200.53 7.22% 175.20 171.58 2.11% 219.19 161.53 35.70% 198.79 175.68 13.15%
EBITDA 42.83 40.86 4.82% 25.69 33.84 -24.08% 25.51 30.12 -15.31% 46.60 28.16 65.48%
EBIDTM 16.61% 16.93% 12.79% 16.47% 10.43% 15.72% 18.99% 13.81%
Other Income 0.29 0.61 -52.46% 2.06 0.70 194.29% 14.60 1.78 720.22% 0.20 1.02 -80.39%
Interest 3.56 3.51 1.42% 3.84 5.37 -28.49% 4.58 7.07 -35.22% 4.44 5.69 -21.97%
Depreciation 11.98 9.27 29.23% 11.83 8.86 33.52% 11.14 7.63 46.00% 10.41 7.82 33.12%
PBT 27.58 28.69 -3.87% 12.07 20.31 -40.57% 24.39 17.20 41.80% 31.95 15.67 103.89%
Tax 7.21 7.25 -0.55% 3.34 5.15 -35.15% 7.10 26.49 -73.20% 5.21 4.56 14.25%
PAT 20.37 21.44 -4.99% 8.73 15.16 -42.41% 17.29 -9.30 - 26.74 11.11 140.68%
PATM 7.90% 8.88% 4.35% 7.38% 7.07% -4.85% 10.90% 5.45%
EPS 15.79 16.62 -4.99% 6.77 11.75 -42.38% 13.40 -7.21 - 20.72 8.61 140.65%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 948.84 936.91 762.71 666.83 527.41 578.89 509.97 469.15 465.69 460.59 448.23 Net Sales Growth 12.65% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% 2.76% Cost Of Goods Sold 419.43 438.42 380.20 366.24 238.37 262.90 253.46 243.99 246.53 269.20 284.69 Gross Profit 529.41 498.50 382.51 300.59 289.04 315.99 256.52 225.16 219.16 191.39 163.54 GP Margin 55.80% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% 36.49% Total Expenditure 808.49 790.47 661.25 608.96 477.38 473.20 430.10 402.79 395.39 403.14 402.05 Power & Fuel Cost - 39.21 32.75 26.81 25.95 25.78 22.24 22.53 18.31 18.97 15.84 % Of Sales - 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% 3.53% Employee Cost - 144.02 118.48 104.47 95.73 84.92 59.89 49.16 36.26 34.88 30.78 % Of Sales - 15.37% 15.53% 15.67% 18.15% 14.67% 11.74% 10.48% 7.79% 7.57% 6.87% Manufacturing Exp. - 81.08 64.84 50.10 55.54 44.90 39.31 43.56 40.98 35.86 33.76 % Of Sales - 8.65% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% 7.53% General & Admin Exp. - 37.42 25.18 24.56 30.38 25.23 26.90 20.77 14.50 14.43 12.27 % Of Sales - 3.99% 3.30% 3.68% 5.76% 4.36% 5.27% 4.43% 3.11% 3.13% 2.74% Selling & Distn. Exp. - 38.41 26.59 28.01 26.50 23.14 26.41 20.31 33.64 21.35 18.89 % Of Sales - 4.10% 3.49% 4.20% 5.02% 4.00% 5.18% 4.33% 7.22% 4.64% 4.21% Miscellaneous Exp. - 11.93 13.21 8.76 4.91 6.34 1.89 2.47 5.17 8.45 18.89 % Of Sales - 1.27% 1.73% 1.31% 0.93% 1.10% 0.37% 0.53% 1.11% 1.83% 1.29% EBITDA 140.34 146.44 101.46 57.87 50.03 105.69 79.87 66.36 70.30 57.45 46.18 EBITDA Margin 14.79% 15.63% 13.30% 8.68% 9.49% 18.26% 15.66% 14.14% 15.10% 12.47% 10.30% Other Income 17.15 16.09 3.89 3.49 4.53 1.17 1.62 0.78 3.41 4.00 2.16 Interest 16.42 17.90 21.57 15.66 18.92 21.08 24.47 27.35 24.55 31.33 33.27 Depreciation 45.36 39.68 31.28 25.86 22.10 19.23 15.74 15.32 14.94 14.62 14.89 PBT 95.70 104.96 52.50 19.84 13.54 66.55 41.28 24.48 34.22 15.50 0.18 Tax 22.83 24.67 36.62 3.69 1.73 20.17 14.87 8.70 7.56 1.86 -1.85 Tax Rate 23.86% 23.50% 69.75% 18.60% 12.78% 30.31% 36.02% 35.54% 22.09% 12.00% -1027.78% PAT 72.88 80.29 15.88 16.14 11.81 46.38 26.41 15.78 26.67 13.64 2.03 PAT before Minority Interest 72.88 80.29 15.88 16.14 11.81 46.38 26.41 15.78 26.67 13.64 2.03 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.68% 8.57% 2.08% 2.42% 2.24% 8.01% 5.18% 3.36% 5.73% 2.96% 0.45% PAT Growth 91.34% 405.60% -1.61% 36.66% -74.54% 75.62% 67.36% -40.83% 95.53% 571.92% EPS 56.94 62.73 12.41 12.61 9.23 36.23 20.63 12.33 20.84 10.66 1.59

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 948.84 936.91 762.71 666.83 527.41 578.89 509.97 469.15 465.69 460.59 448.50 Net Sales Growth 12.65% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% 2.70% Cost Of Goods Sold 419.43 438.42 380.20 366.24 238.37 262.90 253.46 243.99 246.53 269.20 284.69 Gross Profit 529.41 498.50 382.51 300.59 289.04 315.99 256.52 225.16 219.16 191.39 163.81 GP Margin 55.80% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% 36.52% Total Expenditure 808.19 790.09 660.82 608.46 476.98 472.55 429.52 402.53 395.08 402.91 401.69 Power & Fuel Cost - 39.21 32.75 26.81 25.95 25.78 22.24 22.53 18.31 18.97 15.84 % Of Sales - 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% 3.53% Employee Cost - 149.74 123.56 110.46 102.99 92.74 65.38 51.81 41.74 40.75 35.92 % Of Sales - 15.98% 16.20% 16.56% 19.53% 16.02% 12.82% 11.04% 8.96% 8.85% 8.01% Manufacturing Exp. - 81.08 64.84 50.10 55.54 44.90 39.31 43.56 40.98 35.86 33.76 % Of Sales - 8.65% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% 7.53% General & Admin Exp. - 38.93 27.75 27.49 33.32 28.30 29.72 23.59 15.95 16.27 14.27 % Of Sales - 4.16% 3.64% 4.12% 6.32% 4.89% 5.83% 5.03% 3.43% 3.53% 3.18% Selling & Distn. Exp. - 30.65 18.30 18.28 14.04 11.16 17.52 14.54 26.57 13.51 11.42 % Of Sales - 3.27% 2.40% 2.74% 2.66% 1.93% 3.44% 3.10% 5.71% 2.93% 2.55% Miscellaneous Exp. - 12.08 13.42 9.08 6.77 6.78 1.89 2.52 4.99 8.35 11.42 % Of Sales - 1.29% 1.76% 1.36% 1.28% 1.17% 0.37% 0.54% 1.07% 1.81% 1.29% EBITDA 140.63 146.82 101.89 58.37 50.43 106.34 80.45 66.62 70.61 57.68 46.81 EBITDA Margin 14.82% 15.67% 13.36% 8.75% 9.56% 18.37% 15.78% 14.20% 15.16% 12.52% 10.44% Other Income 17.15 16.10 3.89 3.49 4.53 1.17 1.78 0.78 3.44 4.06 2.19 Interest 16.42 17.90 21.57 15.66 18.93 21.09 24.48 27.36 24.56 31.33 33.27 Depreciation 45.36 39.68 31.28 25.86 22.10 19.23 15.74 15.32 14.94 14.62 14.89 PBT 95.99 105.33 52.92 20.34 13.93 67.19 42.00 24.72 34.55 15.78 0.83 Tax 22.86 24.70 36.71 3.90 1.87 20.32 14.92 8.79 7.80 1.96 -1.74 Tax Rate 23.81% 23.45% 69.37% 19.17% 13.42% 30.24% 35.52% 35.56% 22.58% 12.42% -209.64% PAT 73.13 80.63 16.21 16.44 12.06 46.86 27.33 15.94 26.80 13.86 2.56 PAT before Minority Interest 73.13 80.63 16.21 16.44 12.06 46.86 27.08 15.93 26.75 13.82 2.57 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.01 0.05 0.04 -0.01 PAT Margin 7.71% 8.61% 2.13% 2.47% 2.29% 8.09% 5.36% 3.40% 5.75% 3.01% 0.57% PAT Growth 90.39% 397.41% -1.40% 36.32% -74.26% 71.46% 71.46% -40.52% 93.36% 441.41% EPS 57.13 62.99 12.66 12.84 9.42 36.61 21.35 12.45 20.94 10.83 2.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 781.88 705.55 695.58 554.78 542.78 184.17 159.83 122.60 98.58 75.10 Share Capital 12.90 12.90 12.90 8.95 8.95 8.95 8.95 7.73 7.72 5.47 Total Reserves 768.98 692.64 682.68 234.98 222.97 175.22 150.87 114.87 90.87 69.61 Non-Current Liabilities 168.68 162.21 103.13 145.78 53.83 69.01 54.58 52.20 61.85 58.90 Secured Loans 88.13 77.37 60.72 103.49 29.81 33.40 21.22 8.87 26.11 55.90 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 12.00 12.00 25.00 25.00 0.00 Long Term Provisions 9.10 12.18 11.74 9.87 9.28 6.85 6.38 5.14 4.71 3.85 Current Liabilities 372.96 361.99 331.19 370.38 288.24 270.16 296.76 308.46 264.23 289.58 Trade Payables 156.75 120.00 124.00 129.01 88.64 86.17 111.76 93.37 81.49 110.67 Other Current Liabilities 158.59 71.55 57.33 40.57 47.11 54.90 33.16 66.15 42.62 41.44 Short Term Borrowings 56.98 168.17 149.06 199.20 151.08 123.63 145.80 139.62 132.47 132.03 Short Term Provisions 0.64 2.27 0.80 1.59 1.41 5.47 6.04 9.33 7.65 5.43 Total Liabilities 1,323.52 1,229.75 1,129.90 1,070.94 884.85 523.34 511.17 483.26 424.66 423.58 Net Block 696.92 622.75 511.67 445.01 435.74 138.77 123.07 130.85 135.52 151.29 Gross Block 826.45 714.31 575.42 483.45 454.74 291.78 263.65 258.54 250.39 254.07 Accumulated Depreciation 129.53 91.56 63.75 38.44 19.00 153.00 140.58 127.69 114.87 102.78 Non Current Assets 775.34 715.91 676.96 624.22 510.60 210.00 196.04 196.38 198.10 202.38 Capital Work in Progress 17.25 23.75 104.47 126.09 19.60 40.48 41.47 34.56 35.69 27.15 Non Current Investment 19.50 30.33 30.37 30.37 30.36 7.55 7.67 7.64 7.64 7.67 Long Term Loans & Adv. 41.66 35.78 30.45 22.52 24.69 22.71 23.83 23.32 11.16 5.68 Other Non Current Assets 0.00 3.30 0.00 0.22 0.22 0.50 0.00 0.00 8.09 10.59 Current Assets 548.18 513.83 452.93 446.73 374.24 313.34 315.13 286.89 226.56 221.20 Current Investments 6.46 7.50 7.50 7.50 7.50 0.00 0.00 0.00 0.00 0.00 Inventories 247.61 219.55 192.65 175.09 135.11 126.66 113.40 93.42 92.17 92.42 Sundry Debtors 217.73 189.89 164.02 193.92 181.11 119.11 128.85 118.59 98.50 96.41 Cash & Bank 18.08 45.69 37.35 17.05 12.04 9.04 6.49 6.68 0.28 1.78 Other Current Assets 58.31 17.42 19.64 16.24 38.47 58.53 66.39 68.19 35.61 30.59 Short Term Loans & Adv. 46.62 33.79 31.77 36.93 25.03 46.54 45.17 42.73 25.80 18.91 Net Current Assets 175.22 151.84 121.74 76.35 86.00 43.18 18.37 -21.58 -37.67 -68.38 Total Assets 1,323.52 1,229.74 1,129.89 1,070.95 884.84 523.34 511.17 483.27 424.66 423.58

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 786.46 709.96 699.31 558.04 545.62 186.63 161.38 123.99 99.83 76.12 Share Capital 12.90 12.90 12.90 8.95 8.95 8.95 8.95 7.73 7.72 5.47 Total Reserves 773.56 697.06 686.41 238.24 225.81 177.68 152.42 116.26 92.12 70.63 Non-Current Liabilities 169.82 163.39 104.06 146.43 54.37 69.42 54.76 52.33 61.85 58.90 Secured Loans 88.13 77.37 60.72 103.49 29.81 33.40 21.22 8.87 26.11 55.90 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 12.00 12.00 25.00 25.00 0.00 Long Term Provisions 9.44 12.49 11.91 9.87 9.28 6.85 6.38 5.14 4.71 3.85 Current Liabilities 368.51 357.63 326.98 366.93 285.60 268.00 295.14 306.90 262.99 288.53 Trade Payables 152.13 115.56 119.68 124.29 85.92 83.86 111.81 93.94 82.02 110.85 Other Current Liabilities 158.75 71.63 57.45 41.83 47.18 55.02 31.28 63.74 40.46 40.10 Short Term Borrowings 56.98 168.17 149.06 199.20 151.08 123.63 145.80 139.62 132.68 132.03 Short Term Provisions 0.64 2.27 0.80 1.59 1.41 5.50 6.25 9.61 7.83 5.54 Total Liabilities 1,324.79 1,230.98 1,130.35 1,071.40 885.59 524.05 511.53 483.48 424.98 423.91 Net Block 696.94 622.76 511.69 445.01 435.74 138.77 123.07 130.85 135.52 151.29 Gross Block 826.48 714.33 575.44 483.45 454.74 291.78 263.65 258.54 250.39 254.07 Accumulated Depreciation 129.54 91.57 63.75 38.44 19.00 153.00 140.58 127.69 114.87 102.78 Non Current Assets 775.20 715.79 676.88 624.20 510.54 209.87 195.76 195.93 197.66 201.92 Capital Work in Progress 17.25 23.75 104.47 126.09 19.60 40.48 41.47 34.56 35.69 27.15 Non Current Investment 19.35 30.17 30.21 30.21 30.20 7.39 7.39 7.36 7.36 7.39 Long Term Loans & Adv. 41.67 35.81 30.51 22.66 24.79 22.73 23.83 23.15 10.99 5.50 Other Non Current Assets 0.00 3.30 0.00 0.22 0.22 0.50 0.00 0.00 8.09 10.59 Current Assets 549.59 515.19 453.47 447.19 375.04 314.19 315.77 287.55 227.32 221.98 Current Investments 6.46 7.50 7.50 7.50 7.50 0.00 0.00 0.00 0.00 0.00 Inventories 247.61 219.55 192.65 175.09 135.11 126.66 113.40 93.42 92.17 92.42 Sundry Debtors 217.73 189.89 164.02 193.92 181.11 119.11 128.85 118.59 98.50 96.41 Cash & Bank 19.40 46.98 37.84 17.26 12.49 9.71 6.98 7.07 1.18 2.70 Other Current Assets 58.39 17.47 19.69 16.28 38.83 58.70 66.53 68.47 35.48 30.45 Short Term Loans & Adv. 46.62 33.80 31.77 37.15 25.30 46.68 45.23 43.01 25.66 18.75 Net Current Assets 181.08 157.55 126.49 80.27 89.45 46.18 20.63 -19.35 -35.66 -66.54 Total Assets 1,324.79 1,230.98 1,130.35 1,071.39 885.58 524.06 511.53 483.48 424.98 423.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 189.28 56.63 69.60 11.52 38.89 44.65 13.07 48.53 26.16 49.22 PBT 104.96 52.50 19.84 13.54 66.55 41.28 24.48 34.22 15.50 0.18 Adjustment 40.17 58.14 38.93 40.35 43.95 33.85 36.35 34.39 42.26 44.29 Changes in Working Capital 49.34 -49.30 15.92 -39.20 -55.25 -18.76 -38.74 -16.75 -30.81 5.23 Cash after chg. in Working capital 194.47 61.33 74.68 14.69 55.25 56.38 22.08 51.86 26.95 49.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.19 -4.70 -5.09 -3.17 -16.36 -11.73 -9.01 -3.33 -0.79 -0.48 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -84.42 -48.68 -77.22 -116.29 -42.11 -19.86 -14.13 -9.78 -7.22 -5.21 Net Fixed Assets -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 -7.74 Net Investments 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 0.00 Others 9.35 9.45 -6.87 18.92 130.28 7.16 -2.08 -2.76 -2.39 2.53 Cash from Financing Activity -113.66 -5.48 11.98 104.86 -0.08 -23.62 1.15 -38.74 -20.16 -43.70 Net Cash Inflow / Outflow -8.80 2.47 4.36 0.09 -3.30 1.18 0.08 0.00 -1.22 0.31 Opening Cash & Equivalents 9.92 7.44 3.08 3.00 6.29 0.32 0.23 0.23 1.45 1.13 Closing Cash & Equivalent 1.12 9.92 7.44 3.08 3.00 1.49 0.32 0.23 0.23 1.45

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 189.36 57.34 69.91 11.27 38.68 44.83 13.17 48.77 25.83 49.34 PBT 105.33 52.92 20.34 13.93 67.19 42.00 24.72 34.55 15.78 0.83 Adjustment 40.08 58.28 39.11 40.43 43.96 33.73 36.34 34.37 42.22 44.30 Changes in Working Capital 49.22 -49.17 15.47 -40.02 -55.94 -19.17 -38.76 -16.82 -31.35 4.72 Cash after chg. in Working capital 194.63 62.03 74.91 14.35 55.20 56.56 22.30 52.11 26.65 49.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.27 -4.68 -5.01 -3.08 -16.52 -11.73 -9.13 -3.34 -0.82 -0.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -84.42 -48.68 -77.23 -116.29 -42.11 -19.86 -14.13 -9.84 -7.22 -5.21 Net Fixed Assets -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 -7.74 Net Investments 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 0.00 Others 9.35 9.45 -6.88 18.92 130.28 7.16 -2.08 -2.82 -2.39 2.53 Cash from Financing Activity -113.66 -5.48 11.98 104.85 -0.09 -23.62 1.15 -38.96 -19.90 -43.70 Net Cash Inflow / Outflow -8.72 3.18 4.66 -0.17 -3.51 1.35 0.19 -0.03 -1.28 0.42 Opening Cash & Equivalents 11.20 7.94 3.29 3.44 6.97 0.81 0.62 0.65 1.93 1.51 Closing Cash & Equivalent 2.44 11.20 7.94 3.29 3.44 2.16 0.81 0.62 0.65 1.93

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 608.71 549.21 541.45 273.54 260.03 206.30 178.97 151.75 121.84 130.84 ROA 6.29% 1.35% 1.47% 1.21% 6.59% 5.11% 3.17% 5.87% 3.22% 0.48% ROE 10.81% 2.27% 3.44% 4.98% 22.39% 15.44% 11.25% 24.35% 15.92% 2.79% ROCE 12.83% 7.84% 3.95% 4.04% 15.94% 18.46% 15.74% 18.97% 15.55% 11.16% Fixed Asset Turnover 1.22 1.18 1.26 1.13 1.57 1.86 1.82 1.87 1.86 1.82 Receivable days 79.40 84.68 97.96 129.34 93.22 87.45 94.81 83.45 75.67 78.77 Inventory Days 91.00 98.63 100.64 106.98 81.29 84.66 79.24 71.34 71.66 69.27 Payable days 64.00 67.56 78.05 84.05 68.43 85.33 91.74 81.35 87.51 96.88 Cash Conversion Cycle 106.39 115.76 120.56 152.27 106.08 86.78 82.31 73.45 59.82 51.16 Total Debt/Equity 0.22 0.37 0.33 1.31 0.83 0.99 1.18 1.56 2.16 2.98 Interest Cover 6.86 3.43 2.27 1.72 4.16 2.69 1.90 2.39 1.49 1.01

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 612.28 552.65 544.35 277.21 263.23 209.07 180.72 153.48 123.40 132.65 ROA 6.31% 1.37% 1.49% 1.23% 6.65% 5.23% 3.20% 5.89% 3.26% 0.60% ROE 10.79% 2.30% 3.48% 5.02% 22.34% 15.64% 11.24% 24.14% 15.92% 3.49% ROCE 12.81% 7.85% 3.99% 4.07% 15.98% 18.57% 15.75% 18.99% 15.58% 11.35% Fixed Asset Turnover 1.22 1.18 1.26 1.13 1.57 1.86 1.82 1.87 1.86 1.82 Receivable days 79.40 84.68 97.96 129.34 93.22 87.45 94.81 83.45 75.67 78.78 Inventory Days 91.00 98.63 100.64 106.98 81.29 84.66 79.24 71.34 71.66 69.23 Payable days 62.06 65.43 75.72 82.06 67.03 85.01 92.70 82.14 88.22 97.55 Cash Conversion Cycle 108.34 117.88 122.89 154.27 107.48 87.10 81.35 72.66 59.11 50.45 Total Debt/Equity 0.22 0.37 0.33 1.30 0.82 0.98 1.17 1.55 2.13 2.93 Interest Cover 6.89 3.45 2.30 1.74 4.19 2.72 1.90 2.41 1.50 1.02

Top Investors:

malabar india fund limited

malabar value fund

matthews india fund

mukul mahavir agrawal

kedia securities private limited

Annual Reports:

News Update:

Neuland Laboratories - Quarterly Results
29th Oct 2021, 14:37 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback